{"id":10879,"date":"2022-03-29T14:00:08","date_gmt":"2022-03-29T17:00:08","guid":{"rendered":"https:\/\/site.redlearning.cl\/?p=10879"},"modified":"2022-03-29T14:02:20","modified_gmt":"2022-03-29T17:02:20","slug":"un-nuevo-tratamiento-frena-el-avance-del-cancer-de-mama","status":"publish","type":"post","link":"https:\/\/site.redlearning.cl\/?p=10879","title":{"rendered":"Un nuevo tratamiento frena el avance del c\u00e1ncer de mama"},"content":{"rendered":"\n<p>La lucha contra el c\u00e1ncer ha sido exhaustiva a lo largo de la historia, pero existen buenas noticias, ya que existe un f\u00e1rmaco que combate el c\u00e1ncer de mama metast\u00e1sico y multiplica la supervivencia<\/p>\n\n\n\n<p>De acuerdo al ensayo cl\u00ednico internacional&nbsp;<strong><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2115022\" target=\"_blank\" rel=\"noreferrer noopener\">Destiny Breast-03<\/a><\/strong> que ha estudiado la eficacia y seguridad de <em>Trastuzumab deruxtecan<\/em>, un nuevo f\u00e1rmaco que frena el avance del&nbsp;<strong><a href=\"http:\/\/www.enfermeria21.com\/diario-dicen\/investigadores-del-hospital-vall-dhebron-hallan-un-farmaco-eficaz-para-frenar-la-metastasis-del-cancer-de-mama\/\">c\u00e1ncer de mama metast\u00e1sico<\/a><\/strong>.<\/p>\n\n\n\n<p>Este f\u00e1rmaco act\u00faa entrando dentro de las c\u00e9lulas tumorales y destruirlas. El estudio, que se public\u00f3 el jueves pasado en la revista cient\u00edfica\u00a0<strong><a href=\"https:\/\/www.nejm.org\/\" target=\"_blank\" rel=\"noreferrer noopener\">The New England Journal of Medicine<\/a><\/strong>, cuenta con los resultados m\u00e1s esperanzadores en la historia del c\u00e1ncer de mama, seg\u00fan el doctor Javier Cort\u00e9s, director del International Breast Cancer Center (IBCC), primer autor y \u00fanico investigador espa\u00f1ol del ensayo, en el que han participado otros cient\u00edficos de \u00e1mbito internacional.<\/p>\n\n\n\n<p>Este f\u00e1rmaco combina un anticuerpo con quimioterapia, lo que se conoce como conjugado anticuerpo-f\u00e1rmaco o ADC. Se administra por v\u00eda intravenosa y viaja a trav\u00e9s de la sangre hasta las c\u00e9lulas tumorales, donde el anticuerpo reconoce la puerta de entrada de estas c\u00e9lulas malignas, en este caso el receptor HER2, entra sin ser detectado y libera la quimioterapia que transporta para destruirlas, sin da\u00f1ar tanto otras c\u00e9lulas sanas.<\/p>\n\n\n\n<p>El 75,8% de las pacientes que recibieron Trastuzumab deruxtecan se mantienen sin que el c\u00e1ncer empeore a los 12 meses, frente al 34,1% en el caso del grupo al que se le administr\u00f3 el tratamiento est\u00e1ndar. Adem\u00e1s, en un 16% de los casos el tumor ha llegado a desaparecer tras la administraci\u00f3n del nuevo f\u00e1rmaco.<\/p>\n\n\n\n<p>Los resultados de este estudio ya se presentaron en la sesi\u00f3n presidencial del Congreso de la European Society for Medical Oncology (ESMO) en septiembre de 2021. Ahora, el estudio se ha sometido a la revisi\u00f3n por pares (evaluaci\u00f3n que hacen expertos externos al trabajo) y se ha publicado en el The New England Journal of Medicine, lo que confirma la solidez de los datos obtenidos.<\/p>\n\n\n\n<p>Fuente: <a href=\"https:\/\/www.enfermeria21.com\/diario-dicen\/descubren-un-nuevo-farmaco-que-frena-el-avance-del-cancer-de-mama-metastasico-y-multiplica-la-supervivencia\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/www.enfermeria21.com\/diario-dicen\/descubren-un-nuevo-farmaco-que-frena-el-avance-del-cancer-de-mama-metastasico-y-multiplica-la-supervivencia\/<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La lucha contra el c\u00e1ncer ha sido exhaustiva a lo largo de la historia, pero existen buenas noticias, ya que existe un f\u00e1rmaco que combate el c\u00e1ncer de mama metast\u00e1sico y multiplica la supervivencia De acuerdo al ensayo cl\u00ednico internacional&nbsp;Destiny Breast-03 que ha estudiado la eficacia y seguridad de Trastuzumab deruxtecan, un nuevo f\u00e1rmaco que [&hellip;]<\/p>\n","protected":false},"author":10,"featured_media":10883,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"_joinchat":[],"footnotes":""},"categories":[61],"tags":[243,142,25,16,17],"class_list":["post-10879","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-comunidad","tag-cancer","tag-medicina","tag-profesionales-de-la-salud","tag-redlearning","tag-salud"],"_links":{"self":[{"href":"https:\/\/site.redlearning.cl\/index.php?rest_route=\/wp\/v2\/posts\/10879","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/site.redlearning.cl\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/site.redlearning.cl\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/site.redlearning.cl\/index.php?rest_route=\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/site.redlearning.cl\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=10879"}],"version-history":[{"count":3,"href":"https:\/\/site.redlearning.cl\/index.php?rest_route=\/wp\/v2\/posts\/10879\/revisions"}],"predecessor-version":[{"id":10886,"href":"https:\/\/site.redlearning.cl\/index.php?rest_route=\/wp\/v2\/posts\/10879\/revisions\/10886"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/site.redlearning.cl\/index.php?rest_route=\/wp\/v2\/media\/10883"}],"wp:attachment":[{"href":"https:\/\/site.redlearning.cl\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=10879"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/site.redlearning.cl\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=10879"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/site.redlearning.cl\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=10879"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}